世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 経皮吸収型テープ製剤-世界市場シェアとランキング、全体売上高と需要予測 2025-2031Transdermal Drug Patches- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 経皮吸収型テープ製剤の世界市場規模は、2024年には6億9,566万米ドルと推定され、2031年には7億9,000万米ドルに再調整されると予測され、予測期間2025-2031年の年平均成長率は1.9%である。 経皮パッチは、皮膚... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリー経皮吸収型テープ製剤の世界市場規模は、2024年には6億9,566万米ドルと推定され、2031年には7億9,000万米ドルに再調整されると予測され、予測期間2025-2031年の年平均成長率は1.9%である。経皮パッチは、皮膚に貼る薬用粘着パッチで、皮膚から血流に特定量の薬剤を送り込む。経皮吸収パッチには、フェンタニル経皮吸収パッチ、ニコチン経皮吸収パッチ、ブプレノルフィン経皮吸収パッチ、クロニジン経皮吸収パッチ、オキシブチニン経皮吸収パッチ、エストラジオール経皮吸収パッチ、ニトログリセリン経皮吸収パッチなどがある。 経皮吸収型テープ製剤の世界的な主要企業は、久光製薬、ジョンソン・エンド・ジョンソン、マイラン、UCBファーマ、ノバルティスなどである。上位5社のシェアは約37％である。北米が最大市場で約50％のシェア、次いで欧州とアジア太平洋が続き、いずれも約24％のシェアである。 本レポートは、経皮吸収型テープ製剤の世界市場について、地域別・国別、タイプ別、用途別の分析とともに、総販売量、販売収益、価格、主要企業の市場シェア、ランキングを中心に包括的に紹介することを目的としています。 経皮吸収型テープ製剤の市場規模、推計、予測は、2024年を基準年として、2020年から2031年までの期間の履歴データと予測データとともに、販売数量（Mピース）と販売収益（百万ドル）で提供されます。量的および質的分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、経皮吸収型テープ製剤に関する十分な情報に基づいたビジネス上の意思決定を行えるよう支援します。 市場区分 企業別 久光製薬 ジョンソン・エンド・ジョンソン マイラン UCBファーマ ノバルティス テバ製薬 北京タイド製薬 チャテム 日東電工 グリュネンタール ムンディファーマ GSK Luye Pharmaグループ バイエル IBSAグループ ドクター・レディーズ・ラボラトリーズ タイプ別セグメント サリチル酸メチルベースのパッチ リバスチグミン経皮吸収パッチ フェンタニル経皮吸収パッチ リドカインパッチ ジクロフェナクパッチ ニコチン経皮吸収パッチ その他 用途別セグメント Rxチャンネル OTCチャネル 地域別 北米 米国 カナダ アジア太平洋 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア太平洋地域 ヨーロッパ ドイツ フランス 英国 イタリア オランダ 北欧諸国 その他のヨーロッパ ラテンアメリカ メキシコ ブラジル その他のラテンアメリカ 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 その他のMEA 各章の概要 第1章： レポートの対象範囲、世界の総市場規模（金額、数量、価格）を紹介します。また本章では、市場ダイナミクス、市場の最新動向、市場の促進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析を提供します。 第2章：経皮吸収型テープ製剤メーカーの競争環境、価格、売上高、市場シェア、最新の開発計画、合併・買収情報などを詳細に分析します。 第3章：タイプ別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる市場セグメントにおけるブルーオーシャン市場を見つけるのに役立ちます。 第4章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる川下市場のブルーオーシャン市場を見つけるのに役立ちます。 第5章：地域レベルでの経皮吸収型テープ製剤の売上、収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来発展見込み、市場空間、市場規模を紹介しています。 第6章：経皮吸収型テープ製剤の国別売上高、収益。各国・地域のタイプ別、用途別のシグメイトデータを提供。 第7章：主要企業のプロファイルを提供し、製品の売上高、収益、価格、売上総利益率、製品紹介、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介します。 第8章：産業の上流と下流を含む産業チェーンの分析。 第9章：結論 目次1 Market Overview1.1 Transdermal Drug Patches Product Introduction 1.2 Global Transdermal Drug Patches Market Size Forecast 1.2.1 Global Transdermal Drug Patches Sales Value (2020-2031) 1.2.2 Global Transdermal Drug Patches Sales Volume (2020-2031) 1.2.3 Global Transdermal Drug Patches Sales Price (2020-2031) 1.3 Transdermal Drug Patches Market Trends & Drivers 1.3.1 Transdermal Drug Patches Industry Trends 1.3.2 Transdermal Drug Patches Market Drivers & Opportunity 1.3.3 Transdermal Drug Patches Market Challenges 1.3.4 Transdermal Drug Patches Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Transdermal Drug Patches Players Revenue Ranking (2024) 2.2 Global Transdermal Drug Patches Revenue by Company (2020-2025) 2.3 Global Transdermal Drug Patches Players Sales Volume Ranking (2024) 2.4 Global Transdermal Drug Patches Sales Volume by Company Players (2020-2025) 2.5 Global Transdermal Drug Patches Average Price by Company (2020-2025) 2.6 Key Manufacturers Transdermal Drug Patches Manufacturing Base and Headquarters 2.7 Key Manufacturers Transdermal Drug Patches Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Transdermal Drug Patches 2.9 Transdermal Drug Patches Market Competitive Analysis 2.9.1 Transdermal Drug Patches Market Concentration Rate (2020-2025) 2.9.2 Global 5 and 10 Largest Manufacturers by Transdermal Drug Patches Revenue in 2024 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Patches as of 2024) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Methyl Salicylate-based Patch 3.1.2 Rivastigmine Transdermal Patch 3.1.3 Fentanyl Transdermal Patch 3.1.4 Lidocaine Patch 3.1.5 Diclofenac Patch 3.1.6 Nicotine Transdermal Patch 3.1.7 Others 3.2 Global Transdermal Drug Patches Sales Value by Type 3.2.1 Global Transdermal Drug Patches Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Transdermal Drug Patches Sales Value, by Type (2020-2031) 3.2.3 Global Transdermal Drug Patches Sales Value, by Type (%) (2020-2031) 3.3 Global Transdermal Drug Patches Sales Volume by Type 3.3.1 Global Transdermal Drug Patches Sales Volume by Type (2020 VS 2024 VS 2031) 3.3.2 Global Transdermal Drug Patches Sales Volume, by Type (2020-2031) 3.3.3 Global Transdermal Drug Patches Sales Volume, by Type (%) (2020-2031) 3.4 Global Transdermal Drug Patches Average Price by Type (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Rx Channel 4.1.2 OTC Channel 4.2 Global Transdermal Drug Patches Sales Value by Application 4.2.1 Global Transdermal Drug Patches Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Transdermal Drug Patches Sales Value, by Application (2020-2031) 4.2.3 Global Transdermal Drug Patches Sales Value, by Application (%) (2020-2031) 4.3 Global Transdermal Drug Patches Sales Volume by Application 4.3.1 Global Transdermal Drug Patches Sales Volume by Application (2020 VS 2024 VS 2031) 4.3.2 Global Transdermal Drug Patches Sales Volume, by Application (2020-2031) 4.3.3 Global Transdermal Drug Patches Sales Volume, by Application (%) (2020-2031) 4.4 Global Transdermal Drug Patches Average Price by Application (2020-2031) 5 Segmentation by Region 5.1 Global Transdermal Drug Patches Sales Value by Region 5.1.1 Global Transdermal Drug Patches Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Transdermal Drug Patches Sales Value by Region (2020-2025) 5.1.3 Global Transdermal Drug Patches Sales Value by Region (2026-2031) 5.1.4 Global Transdermal Drug Patches Sales Value by Region (%), (2020-2031) 5.2 Global Transdermal Drug Patches Sales Volume by Region 5.2.1 Global Transdermal Drug Patches Sales Volume by Region: 2020 VS 2024 VS 2031 5.2.2 Global Transdermal Drug Patches Sales Volume by Region (2020-2025) 5.2.3 Global Transdermal Drug Patches Sales Volume by Region (2026-2031) 5.2.4 Global Transdermal Drug Patches Sales Volume by Region (%), (2020-2031) 5.3 Global Transdermal Drug Patches Average Price by Region (2020-2031) 5.4 North America 5.4.1 North America Transdermal Drug Patches Sales Value, 2020-2031 5.4.2 North America Transdermal Drug Patches Sales Value by Country (%), 2024 VS 2031 5.5 Europe 5.5.1 Europe Transdermal Drug Patches Sales Value, 2020-2031 5.5.2 Europe Transdermal Drug Patches Sales Value by Country (%), 2024 VS 2031 5.6 Asia Pacific 5.6.1 Asia Pacific Transdermal Drug Patches Sales Value, 2020-2031 5.6.2 Asia Pacific Transdermal Drug Patches Sales Value by Region (%), 2024 VS 2031 5.7 South America 5.7.1 South America Transdermal Drug Patches Sales Value, 2020-2031 5.7.2 South America Transdermal Drug Patches Sales Value by Country (%), 2024 VS 2031 5.8 Middle East & Africa 5.8.1 Middle East & Africa Transdermal Drug Patches Sales Value, 2020-2031 5.8.2 Middle East & Africa Transdermal Drug Patches Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Transdermal Drug Patches Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Transdermal Drug Patches Sales Value 6.2.1 Key Countries/Regions Transdermal Drug Patches Sales Value, 2020-2031 6.2.2 Key Countries/Regions Transdermal Drug Patches Sales Volume, 2020-2031 6.3 United States 6.3.1 United States Transdermal Drug Patches Sales Value, 2020-2031 6.3.2 United States Transdermal Drug Patches Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Transdermal Drug Patches Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Transdermal Drug Patches Sales Value, 2020-2031 6.4.2 Europe Transdermal Drug Patches Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Transdermal Drug Patches Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Transdermal Drug Patches Sales Value, 2020-2031 6.5.2 China Transdermal Drug Patches Sales Value by Type (%), 2024 VS 2031 6.5.3 China Transdermal Drug Patches Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Transdermal Drug Patches Sales Value, 2020-2031 6.6.2 Japan Transdermal Drug Patches Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Transdermal Drug Patches Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Transdermal Drug Patches Sales Value, 2020-2031 6.7.2 South Korea Transdermal Drug Patches Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Transdermal Drug Patches Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Transdermal Drug Patches Sales Value, 2020-2031 6.8.2 Southeast Asia Transdermal Drug Patches Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Transdermal Drug Patches Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Transdermal Drug Patches Sales Value, 2020-2031 6.9.2 India Transdermal Drug Patches Sales Value by Type (%), 2024 VS 2031 6.9.3 India Transdermal Drug Patches Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Hisamitsu Pharmaceutical 7.1.1 Hisamitsu Pharmaceutical Company Information 7.1.2 Hisamitsu Pharmaceutical Introduction and Business Overview 7.1.3 Hisamitsu Pharmaceutical Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.1.4 Hisamitsu Pharmaceutical Transdermal Drug Patches Product Offerings 7.1.5 Hisamitsu Pharmaceutical Recent Development 7.2 Johnson & Johnson 7.2.1 Johnson & Johnson Company Information 7.2.2 Johnson & Johnson Introduction and Business Overview 7.2.3 Johnson & Johnson Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.2.4 Johnson & Johnson Transdermal Drug Patches Product Offerings 7.2.5 Johnson & Johnson Recent Development 7.3 Mylan 7.3.1 Mylan Company Information 7.3.2 Mylan Introduction and Business Overview 7.3.3 Mylan Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.3.4 Mylan Transdermal Drug Patches Product Offerings 7.3.5 Mylan Recent Development 7.4 UCB Pharma 7.4.1 UCB Pharma Company Information 7.4.2 UCB Pharma Introduction and Business Overview 7.4.3 UCB Pharma Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.4.4 UCB Pharma Transdermal Drug Patches Product Offerings 7.4.5 UCB Pharma Recent Development 7.5 Novartis 7.5.1 Novartis Company Information 7.5.2 Novartis Introduction and Business Overview 7.5.3 Novartis Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.5.4 Novartis Transdermal Drug Patches Product Offerings 7.5.5 Novartis Recent Development 7.6 Teva Pharmaceutical 7.6.1 Teva Pharmaceutical Company Information 7.6.2 Teva Pharmaceutical Introduction and Business Overview 7.6.3 Teva Pharmaceutical Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.6.4 Teva Pharmaceutical Transdermal Drug Patches Product Offerings 7.6.5 Teva Pharmaceutical Recent Development 7.7 Beijing Tide Pharmaceutical 7.7.1 Beijing Tide Pharmaceutical Company Information 7.7.2 Beijing Tide Pharmaceutical Introduction and Business Overview 7.7.3 Beijing Tide Pharmaceutical Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.7.4 Beijing Tide Pharmaceutical Transdermal Drug Patches Product Offerings 7.7.5 Beijing Tide Pharmaceutical Recent Development 7.8 Chattem 7.8.1 Chattem Company Information 7.8.2 Chattem Introduction and Business Overview 7.8.3 Chattem Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.8.4 Chattem Transdermal Drug Patches Product Offerings 7.8.5 Chattem Recent Development 7.9 Nitto Denko 7.9.1 Nitto Denko Company Information 7.9.2 Nitto Denko Introduction and Business Overview 7.9.3 Nitto Denko Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.9.4 Nitto Denko Transdermal Drug Patches Product Offerings 7.9.5 Nitto Denko Recent Development 7.10 Grünenthal 7.10.1 Grünenthal Company Information 7.10.2 Grünenthal Introduction and Business Overview 7.10.3 Grünenthal Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.10.4 Grünenthal Transdermal Drug Patches Product Offerings 7.10.5 Grünenthal Recent Development 7.11 Mundipharma 7.11.1 Mundipharma Company Information 7.11.2 Mundipharma Introduction and Business Overview 7.11.3 Mundipharma Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.11.4 Mundipharma Transdermal Drug Patches Product Offerings 7.11.5 Mundipharma Recent Development 7.12 GSK 7.12.1 GSK Company Information 7.12.2 GSK Introduction and Business Overview 7.12.3 GSK Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.12.4 GSK Transdermal Drug Patches Product Offerings 7.12.5 GSK Recent Development 7.13 Luye Pharma Group 7.13.1 Luye Pharma Group Company Information 7.13.2 Luye Pharma Group Introduction and Business Overview 7.13.3 Luye Pharma Group Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.13.4 Luye Pharma Group Transdermal Drug Patches Product Offerings 7.13.5 Luye Pharma Group Recent Development 7.14 Bayer 7.14.1 Bayer Company Information 7.14.2 Bayer Introduction and Business Overview 7.14.3 Bayer Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.14.4 Bayer Transdermal Drug Patches Product Offerings 7.14.5 Bayer Recent Development 7.15 IBSA Group 7.15.1 IBSA Group Company Information 7.15.2 IBSA Group Introduction and Business Overview 7.15.3 IBSA Group Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.15.4 IBSA Group Transdermal Drug Patches Product Offerings 7.15.5 IBSA Group Recent Development 7.16 Dr Reddy’s Laboratories 7.16.1 Dr Reddy’s Laboratories Company Information 7.16.2 Dr Reddy’s Laboratories Introduction and Business Overview 7.16.3 Dr Reddy’s Laboratories Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.16.4 Dr Reddy’s Laboratories Transdermal Drug Patches Product Offerings 7.16.5 Dr Reddy’s Laboratories Recent Development 8 Industry Chain Analysis 8.1 Transdermal Drug Patches Industrial Chain 8.2 Transdermal Drug Patches Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Transdermal Drug Patches Sales Model 8.5.2 Sales Channel 8.5.3 Transdermal Drug Patches Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
SummaryThe global market for Transdermal Drug Patches was estimated to be worth US$ 6956 million in 2024 and is forecast to a readjusted size of US$ 7900 million by 2031 with a CAGR of 1.9% during the forecast period 2025-2031. Table of Contents1 Market Overview1.1 Transdermal Drug Patches Product Introduction 1.2 Global Transdermal Drug Patches Market Size Forecast 1.2.1 Global Transdermal Drug Patches Sales Value (2020-2031) 1.2.2 Global Transdermal Drug Patches Sales Volume (2020-2031) 1.2.3 Global Transdermal Drug Patches Sales Price (2020-2031) 1.3 Transdermal Drug Patches Market Trends & Drivers 1.3.1 Transdermal Drug Patches Industry Trends 1.3.2 Transdermal Drug Patches Market Drivers & Opportunity 1.3.3 Transdermal Drug Patches Market Challenges 1.3.4 Transdermal Drug Patches Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Transdermal Drug Patches Players Revenue Ranking (2024) 2.2 Global Transdermal Drug Patches Revenue by Company (2020-2025) 2.3 Global Transdermal Drug Patches Players Sales Volume Ranking (2024) 2.4 Global Transdermal Drug Patches Sales Volume by Company Players (2020-2025) 2.5 Global Transdermal Drug Patches Average Price by Company (2020-2025) 2.6 Key Manufacturers Transdermal Drug Patches Manufacturing Base and Headquarters 2.7 Key Manufacturers Transdermal Drug Patches Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Transdermal Drug Patches 2.9 Transdermal Drug Patches Market Competitive Analysis 2.9.1 Transdermal Drug Patches Market Concentration Rate (2020-2025) 2.9.2 Global 5 and 10 Largest Manufacturers by Transdermal Drug Patches Revenue in 2024 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Patches as of 2024) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Methyl Salicylate-based Patch 3.1.2 Rivastigmine Transdermal Patch 3.1.3 Fentanyl Transdermal Patch 3.1.4 Lidocaine Patch 3.1.5 Diclofenac Patch 3.1.6 Nicotine Transdermal Patch 3.1.7 Others 3.2 Global Transdermal Drug Patches Sales Value by Type 3.2.1 Global Transdermal Drug Patches Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Transdermal Drug Patches Sales Value, by Type (2020-2031) 3.2.3 Global Transdermal Drug Patches Sales Value, by Type (%) (2020-2031) 3.3 Global Transdermal Drug Patches Sales Volume by Type 3.3.1 Global Transdermal Drug Patches Sales Volume by Type (2020 VS 2024 VS 2031) 3.3.2 Global Transdermal Drug Patches Sales Volume, by Type (2020-2031) 3.3.3 Global Transdermal Drug Patches Sales Volume, by Type (%) (2020-2031) 3.4 Global Transdermal Drug Patches Average Price by Type (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Rx Channel 4.1.2 OTC Channel 4.2 Global Transdermal Drug Patches Sales Value by Application 4.2.1 Global Transdermal Drug Patches Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Transdermal Drug Patches Sales Value, by Application (2020-2031) 4.2.3 Global Transdermal Drug Patches Sales Value, by Application (%) (2020-2031) 4.3 Global Transdermal Drug Patches Sales Volume by Application 4.3.1 Global Transdermal Drug Patches Sales Volume by Application (2020 VS 2024 VS 2031) 4.3.2 Global Transdermal Drug Patches Sales Volume, by Application (2020-2031) 4.3.3 Global Transdermal Drug Patches Sales Volume, by Application (%) (2020-2031) 4.4 Global Transdermal Drug Patches Average Price by Application (2020-2031) 5 Segmentation by Region 5.1 Global Transdermal Drug Patches Sales Value by Region 5.1.1 Global Transdermal Drug Patches Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Transdermal Drug Patches Sales Value by Region (2020-2025) 5.1.3 Global Transdermal Drug Patches Sales Value by Region (2026-2031) 5.1.4 Global Transdermal Drug Patches Sales Value by Region (%), (2020-2031) 5.2 Global Transdermal Drug Patches Sales Volume by Region 5.2.1 Global Transdermal Drug Patches Sales Volume by Region: 2020 VS 2024 VS 2031 5.2.2 Global Transdermal Drug Patches Sales Volume by Region (2020-2025) 5.2.3 Global Transdermal Drug Patches Sales Volume by Region (2026-2031) 5.2.4 Global Transdermal Drug Patches Sales Volume by Region (%), (2020-2031) 5.3 Global Transdermal Drug Patches Average Price by Region (2020-2031) 5.4 North America 5.4.1 North America Transdermal Drug Patches Sales Value, 2020-2031 5.4.2 North America Transdermal Drug Patches Sales Value by Country (%), 2024 VS 2031 5.5 Europe 5.5.1 Europe Transdermal Drug Patches Sales Value, 2020-2031 5.5.2 Europe Transdermal Drug Patches Sales Value by Country (%), 2024 VS 2031 5.6 Asia Pacific 5.6.1 Asia Pacific Transdermal Drug Patches Sales Value, 2020-2031 5.6.2 Asia Pacific Transdermal Drug Patches Sales Value by Region (%), 2024 VS 2031 5.7 South America 5.7.1 South America Transdermal Drug Patches Sales Value, 2020-2031 5.7.2 South America Transdermal Drug Patches Sales Value by Country (%), 2024 VS 2031 5.8 Middle East & Africa 5.8.1 Middle East & Africa Transdermal Drug Patches Sales Value, 2020-2031 5.8.2 Middle East & Africa Transdermal Drug Patches Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Transdermal Drug Patches Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Transdermal Drug Patches Sales Value 6.2.1 Key Countries/Regions Transdermal Drug Patches Sales Value, 2020-2031 6.2.2 Key Countries/Regions Transdermal Drug Patches Sales Volume, 2020-2031 6.3 United States 6.3.1 United States Transdermal Drug Patches Sales Value, 2020-2031 6.3.2 United States Transdermal Drug Patches Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Transdermal Drug Patches Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Transdermal Drug Patches Sales Value, 2020-2031 6.4.2 Europe Transdermal Drug Patches Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Transdermal Drug Patches Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Transdermal Drug Patches Sales Value, 2020-2031 6.5.2 China Transdermal Drug Patches Sales Value by Type (%), 2024 VS 2031 6.5.3 China Transdermal Drug Patches Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Transdermal Drug Patches Sales Value, 2020-2031 6.6.2 Japan Transdermal Drug Patches Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Transdermal Drug Patches Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Transdermal Drug Patches Sales Value, 2020-2031 6.7.2 South Korea Transdermal Drug Patches Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Transdermal Drug Patches Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Transdermal Drug Patches Sales Value, 2020-2031 6.8.2 Southeast Asia Transdermal Drug Patches Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Transdermal Drug Patches Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Transdermal Drug Patches Sales Value, 2020-2031 6.9.2 India Transdermal Drug Patches Sales Value by Type (%), 2024 VS 2031 6.9.3 India Transdermal Drug Patches Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Hisamitsu Pharmaceutical 7.1.1 Hisamitsu Pharmaceutical Company Information 7.1.2 Hisamitsu Pharmaceutical Introduction and Business Overview 7.1.3 Hisamitsu Pharmaceutical Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.1.4 Hisamitsu Pharmaceutical Transdermal Drug Patches Product Offerings 7.1.5 Hisamitsu Pharmaceutical Recent Development 7.2 Johnson & Johnson 7.2.1 Johnson & Johnson Company Information 7.2.2 Johnson & Johnson Introduction and Business Overview 7.2.3 Johnson & Johnson Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.2.4 Johnson & Johnson Transdermal Drug Patches Product Offerings 7.2.5 Johnson & Johnson Recent Development 7.3 Mylan 7.3.1 Mylan Company Information 7.3.2 Mylan Introduction and Business Overview 7.3.3 Mylan Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.3.4 Mylan Transdermal Drug Patches Product Offerings 7.3.5 Mylan Recent Development 7.4 UCB Pharma 7.4.1 UCB Pharma Company Information 7.4.2 UCB Pharma Introduction and Business Overview 7.4.3 UCB Pharma Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.4.4 UCB Pharma Transdermal Drug Patches Product Offerings 7.4.5 UCB Pharma Recent Development 7.5 Novartis 7.5.1 Novartis Company Information 7.5.2 Novartis Introduction and Business Overview 7.5.3 Novartis Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.5.4 Novartis Transdermal Drug Patches Product Offerings 7.5.5 Novartis Recent Development 7.6 Teva Pharmaceutical 7.6.1 Teva Pharmaceutical Company Information 7.6.2 Teva Pharmaceutical Introduction and Business Overview 7.6.3 Teva Pharmaceutical Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.6.4 Teva Pharmaceutical Transdermal Drug Patches Product Offerings 7.6.5 Teva Pharmaceutical Recent Development 7.7 Beijing Tide Pharmaceutical 7.7.1 Beijing Tide Pharmaceutical Company Information 7.7.2 Beijing Tide Pharmaceutical Introduction and Business Overview 7.7.3 Beijing Tide Pharmaceutical Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.7.4 Beijing Tide Pharmaceutical Transdermal Drug Patches Product Offerings 7.7.5 Beijing Tide Pharmaceutical Recent Development 7.8 Chattem 7.8.1 Chattem Company Information 7.8.2 Chattem Introduction and Business Overview 7.8.3 Chattem Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.8.4 Chattem Transdermal Drug Patches Product Offerings 7.8.5 Chattem Recent Development 7.9 Nitto Denko 7.9.1 Nitto Denko Company Information 7.9.2 Nitto Denko Introduction and Business Overview 7.9.3 Nitto Denko Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.9.4 Nitto Denko Transdermal Drug Patches Product Offerings 7.9.5 Nitto Denko Recent Development 7.10 Grünenthal 7.10.1 Grünenthal Company Information 7.10.2 Grünenthal Introduction and Business Overview 7.10.3 Grünenthal Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.10.4 Grünenthal Transdermal Drug Patches Product Offerings 7.10.5 Grünenthal Recent Development 7.11 Mundipharma 7.11.1 Mundipharma Company Information 7.11.2 Mundipharma Introduction and Business Overview 7.11.3 Mundipharma Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.11.4 Mundipharma Transdermal Drug Patches Product Offerings 7.11.5 Mundipharma Recent Development 7.12 GSK 7.12.1 GSK Company Information 7.12.2 GSK Introduction and Business Overview 7.12.3 GSK Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.12.4 GSK Transdermal Drug Patches Product Offerings 7.12.5 GSK Recent Development 7.13 Luye Pharma Group 7.13.1 Luye Pharma Group Company Information 7.13.2 Luye Pharma Group Introduction and Business Overview 7.13.3 Luye Pharma Group Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.13.4 Luye Pharma Group Transdermal Drug Patches Product Offerings 7.13.5 Luye Pharma Group Recent Development 7.14 Bayer 7.14.1 Bayer Company Information 7.14.2 Bayer Introduction and Business Overview 7.14.3 Bayer Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.14.4 Bayer Transdermal Drug Patches Product Offerings 7.14.5 Bayer Recent Development 7.15 IBSA Group 7.15.1 IBSA Group Company Information 7.15.2 IBSA Group Introduction and Business Overview 7.15.3 IBSA Group Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.15.4 IBSA Group Transdermal Drug Patches Product Offerings 7.15.5 IBSA Group Recent Development 7.16 Dr Reddy’s Laboratories 7.16.1 Dr Reddy’s Laboratories Company Information 7.16.2 Dr Reddy’s Laboratories Introduction and Business Overview 7.16.3 Dr Reddy’s Laboratories Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2020-2025) 7.16.4 Dr Reddy’s Laboratories Transdermal Drug Patches Product Offerings 7.16.5 Dr Reddy’s Laboratories Recent Development 8 Industry Chain Analysis 8.1 Transdermal Drug Patches Industrial Chain 8.2 Transdermal Drug Patches Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Transdermal Drug Patches Sales Model 8.5.2 Sales Channel 8.5.3 Transdermal Drug Patches Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療/ヘルスケア）の最新刊レポート
QYResearch社の医薬・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD（drug）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
